genetic disorders
Yourgene Health Gets CE Mark for Iona NIPT Test
The test has been developed to run on Illumina's NextSeq 550Dx next-generation sequencing platform and will be prepared for commercial launch in Europe.
Ravgen Sues Natera Over Cell-Free DNA Genetic Testing Patents
In its complaint, the Maryland-based company claimed that Natera infringes two of its patents, both titled "Methods for detection of genetic disorders."
Invitae Q1 Revenues Grow 58 Percent
The San Francisco-based firm reported $64.2 million in revenues, up from $40.6 million a year ago and beating the average Wall Street estimate of $59.4 million.
Illumina Loses Appeal for Injunction Against Ariosa Diagnostics, but Court Upholds $27M Judgment
Illumina had sought to exclude the Harmony test from the US Market, while Ariosa had sought to overturn the jury verdict with a post-trial maneuver.
Natera Expects 35 Percent Rise in Q1 Revenues, Proposes $250M Senior Notes Offering
The company is withdrawing its previous financial guidance for 2020, saying that it cannot predict the extent or duration of the impact of the COVID-19 pandemic.